Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Savlon Burns & Scalds 0.025% cream
1310050J0BEAAAC
|
Savlon | Chlorhexidine gluconate | Skin | 1 |
|
Scholl Seal and Heal verruca removal gel
1307000M0BQADBL
|
Scholl (Corn & Verruca) | Salicylic acid | Skin | 1 |
|
Spirigel Plus alcohol hand gel
131101000BMAQA0
|
Proprietary compound preparation BNF 1311010 | Other alcohol and saline preparations | Skin | 1 |
|
Stelara 90mg/1ml solution for injection pre-filled syringes
1305030D0BBACAC
|
Stelara | Ustekinumab | Skin | 1 |
|
Sudosalve 0.15% nappy rash treatment cream
1310050K0BDAAAA
|
Sudosalve | Dibrompropamidine isetionate | Skin | 1 |
|
Sulfur 0.5% in Aqueous cream
1306010T0AABIBI
|
Sulfur (Topical) | Sulfur | Skin | 1 |
|
Sulfur 1% in Aqueous cream
1306010T0AAAVAV
|
Sulfur (Topical) | Sulfur | Skin | 1 |
|
Sulfur 2% in Aqueous cream
1306010T0AAATAT
|
Sulfur (Topical) | Sulfur | Skin | 1 |
|
Synalar N cream
1304000N0BBALCB
|
Synalar | Fluocinolone acetonide | Skin | 1 |
|
Tazarotene 0.1% gel
1305020T0AAABAB
|
Tazarotene | Tazarotene | Skin | 1 |
|
Terra-Cortril Nystatin cream
1304000V0CCABCC
|
Terra-Cortril (Topical) | Hydrocortisone | Skin | 1 |
|
Toctino 10mg capsules
1305010AFBBAAAA
|
Toctino | Alitretinoin | Skin | 1 |
|
Tolnaftate 1% powder
1310020Y0AAABAB
|
Tolnaftate | Tolnaftate | Skin | 1 |
|
Tretinoin 0.025% gel
1306010V0AAAMAM
|
Tretinoin (Acne) | Tretinoin | Skin | 1 |
|
Urea 10% in Generic Unguentum M cream
1302010U0AAAZAZ
|
Urea (Emollient) | Urea | Skin | 1 |
|
Ustekinumab 90mg/1ml inj pre-filled syringes
1305030D0AAACAC
|
Ustekinumab | Ustekinumab | Skin | 1 |
|
White soft paraffin 75% / Liquid paraffin 25% ointment
130201000AACWCW
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
Wool fat ointment
1301010W0AAABAB
|
Wool fat | Wool fat | Skin | 1 |
|
Wool fat solid
1301010W0AAAAAA
|
Wool fat | Wool fat | Skin | 1 |
|
Zinc and Coal tar paste
1305020C0AAALAL
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Zinc paste 15% bandage BP 1993 7.5cm x 6m
1302020G0AAAAAA
|
Zinc paste | Zinc paste | Skin | 1 |
|
A-Derma Exomega emollient cream
130201000BBMDA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
AaciGam 40mg capsules
1305010I0BWAAAA
|
AaciGam | Gamolenic acid | Skin | No data available |
|
AaciGam 80mg capsules
1305010I0BWABAB
|
AaciGam | Gamolenic acid | Skin | No data available |
|
Abrocitinib 100mg tablets
1305030K0AAAAAA
|
Abrocitinib | Abrocitinib | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.